LEADER 03172nam  2200985z- 450 
001 9910576883303321
005 20231214133130.0
035   $a(CKB)5720000000008342
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/84479
035   $a(EXLCZ)995720000000008342
100   $a20202206d2022      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPersonalized Medicine in Epidemics
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (160 p.)
311   $a3-0365-4208-6 
311   $a3-0365-4207-8 
330   $aThis reprint contains 11 chapters on a wide range of subjects related to the impacts of different types of epidemics on our ability to practice personalized medicine. Together, these chapters provide a broad overview with many different examples of epidemics. The personalization of medicine is present both despite and because of epidemics. Many more examples are possible, but this reprint offers a primary overview emphasizing the widely spread relevance of the topic.
606   $aMedicine$2bicssc
606   $aPharmacology$2bicssc
610   $adiabetes mellitus
610   $acluster analyses
610   $arisk factors
610   $amicro- and macrovascular disease
610   $ahyperuricemia
610   $asex
610   $arenal progression
610   $achronic kidney disease
610   $adisability
610   $achildren
610   $aoral health
610   $acaries
610   $adental treatment
610   $apersonalized medicine
610   $aprecision medicine
610   $aCovid-19
610   $aSARS CoV2
610   $aepidemiology
610   $ahost genetics
610   $aviral genome
610   $aearly diagnosis
610   $atype 1 diabetes mellitus
610   $aCOVID-19
610   $aepidemics
610   $adiabetic ketoacidosis
610   $ahypertension and type 2 diabetes mellitus comorbidity
610   $aIgG
610   $aN-glycosylation
610   $abiomarkers
610   $atongue pressure
610   $aaging
610   $acommunity
610   $aelderly
610   $atuberculosis
610   $apulmonary function
610   $arespiratory symptoms
610   $aquality of life
610   $ahepatitis C virus
610   $adiffuse large B-cell lymphoma
610   $asurvival
610   $afibrosis
610   $aperformance status
610   $aliver toxicity
610   $aabdominal adiposity
610   $aadolescents
610   $ablood pressure
610   $aobesity
610   $aJordan
610   $aboys
610   $alung cancer screening
610   $asmoking
610   $awillingness to screen
610   $aeducation
615  7$aMedicine
615  7$aPharmacology
700   $aMiddelburg$b Rutger A$4edt$01307636
702   $aMiddelburg$b Rutger A$4oth
906   $aBOOK
912   $a9910576883303321
996   $aPersonalized Medicine in Epidemics$93028885
997   $aUNINA